tiprankstipranks
Trending News
More News >

iTeos Therapeutics downgraded to Equal Weight at Wells Fargo on wind down

As previously reported, Wells Fargo analyst Eva Fortea Verdejo downgraded iTeos Therapeutics (ITOS) to Equal Weight from Overweight with a price target of $12, down from $13, after the company announced plans to wind down operations. Given the termination of the belrestotug development program, the company has only early Phase 1 assets that aren’t de-risked, so the wind down decision “makes sense,” the analyst tells investors.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue